查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
美国深奥测试市场规模和预测、区域份额、趋势和成长机会分析报告范围：按类型、技术和最终用户
市场调查报告书
商品编码
1408675

美国深奥测试市场规模和预测、区域份额、趋势和成长机会分析报告范围：按类型、技术和最终用户

US Esoteric Testing Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Technology, and End User
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 订单完成后即时交付

价格

美国深奥测试市场预计将从2022年的103.82亿美元成长到2030年的312.74亿美元；预计 2022 年至 2030 年CAGR为 14.8%。该报告强调了市场的普遍趋势以及推动市场成长的因素。市场成长归因于慢性病盛行率的上升以及人们对早期发现医疗状况的意识不断增强，这推动了美国深奥检测市场的规模和成长。此外，监管机构在基因检测和罕见疾病相关措施方面的进步可能会成为预测期内市场的重要趋势。然而，缺乏熟练人员和高昂的程序成本阻碍了 2022-2030 年预测期内的市场成长。

早期发现医疗状况的意识不断增强，将推动预测期内的市场发展。

疾病的早​​期诊断有助于医疗专业人员和患者在护理、支持需求以及财务和法律事务方面做出各种重要的医疗决定。在註意到与特定医疗状况相关的认知症状后获得准确和早期的诊断，可以在症状恶化之前逆转症状，从而对患者进行有效和早期的治疗。它还为医疗保健专业人员提供了充足的时间来做出更好的决策。实验室检查程序广泛用于诊断与医学专业相关的疾病，例如神经系统疾病、遗传疾病、癌症和内分泌疾病。深奥的测试和基因测试用于诊断糖尿病、心血管疾病、血脂紊乱、癌症和遗传疾病。

各政府监管机构也在采取措施并开展活动来促进早期诊断实践。国家罕见疾病组织旨在透过教育、研究、宣传和患者服务等众多支持项目来识别、诊断和治疗罕见疾病。纽约州罕见疾病工作小组是根据纽约州通过的立法（《公共卫生法》第 27-L 条）而成立的，旨在确定可以提高对罕见疾病认识的最佳实践。透过这些倡议，可能患有罕见疾病的人可以被转介给专家，并可以解决治疗的障碍，包括经济挑战。这些旨在建立有关复杂遗传和非遗传罕见疾病的可用诊断方案的知识的倡议有利于美国深奥检测市场的成长。

报告细分和范围 -

「美国深奥测试市场」根据类型、技术和最终用户进行细分。依类型，市场分为传染病检测、内分泌检测、肿瘤检测、毒理学检测、免疫学检测、神经学检测等。从技术上来看，美国深奥检测市场分为化学发光免疫分析、酵素连结免疫吸附分析、质谱分析、即时PCR、DNA定序、流式细胞仪等。就最终用户而言，市场分为医院和实验室以及独立和参考实验室。

美国深奥检测市场依类型分为传染病检测、内分泌检测、肿瘤学检测、毒理检测、免疫学检测、神经学检测等。肿瘤检测领域在 2022 年占据最大的市场份额。传染病检测领域预计 2022 年至 2030 年CAGR最高。

根据技术，美国深奥检测市场分为化学发光免疫分析、酵素连结免疫吸附分析、质谱分析、即时PCR、DNA定序、流式细胞仪等。化学发光免疫分析领域在 2022 年占据最大的市场份额。酵素连结免疫吸附分析领域预计在 2022 年至 2030 年期间CAGR最高，达到 18.7%。

根据最终用户，美国深奥检测市场分为医院和实验室，以及独立和参考实验室。 2022 年，医院和实验室领域占据了更大的市场份额。预计 2022 年至 2030 年复合CAGR将达到 15.2%。

深奥测试通常用于分析常规测试中未得出结论的稀有和独特物质。为了进行这些测试，临床实验室需要相关专业的专业知识。因此，大型商业实验室将这些复杂的测试外包给参考和深奥的测试实验室。在美国进行深奥测试的一些实验室包括 Quest Diagnostics Incorporated、Mayo Medical Laboratories、ARUP Laboratories、Myriad Genetics、Genomic Health、Foundation Medicine 和 Laboratory Corporation of America。该地区能够进行这些专业测试的实验室数量正在增加。

根据内分泌学会 2022 年 1 月发表的一篇文章，性腺功能减退症是男性人群中的常见病症，在老年男性、肥胖男性和 2 型糖尿病男性中患病率较高。据估计，45 岁以上男性中 35% 以及患有第 2 型糖尿病或肥胖症的男性中 30-50% 患有性腺功能减退症。此外，根据美国人口普查局的估计，65岁及以上男性性腺功能减退症的发生率从2000年的约3500万增至2020年的约5500万。此外，预计到2050年将增至约8700万。这种疾病的盛行率激增是由于美国老年人口的增加。

对深奥检测的需求激增也归因于肝硬化病例的增加。根据 Statista 的数据，2020 年美国有 51,642 名成年人死于肝病。慢性肝病/肝硬化是 2020 年美国第 12 大死因；酒精性肝硬化发生率的增加是这种疾病的主要危险因子。

此外，合作和伙伴关係也有望推动美国深奥测试的市场成长。例如，根据美国国立卫生研究院(NIH) 2021 年10 月的新闻稿，NIH、美国食品和药物管理局、10 家製药公司和5 家非营利组织已联合起来，加快针对30 名患者的基因疗法的开发。数百万美国人患有罕见疾病。儘管有近 7,000 种罕见疾病，但目前只有 2 种遗传性疾病拥有 FDA 批准的基因疗法。最近成立的客製化基因治疗联盟 (BGTC) 是 NIH 加速药物合作伙伴 (AMP) 计划的一部分，由 NIH 基金会牵头，旨在加强和简化基因治疗的开发流程，以支持未满足的医疗需求患有罕见疾病的人。

因此，性腺功能减退症、肝硬化和其他此类疾病的病例不断增加，正在推动美国深奥检测市场的成长。

美国深奥测试市场的公司采用各种有机和无机策略。有机策略主要包括产品发布和产品批准。此外，市场上出现的无机成长策略包括收购、合作和伙伴关係。这些成长策略使市场参与者能够扩大业务并增强其地理影响力，从而促进整体市场的成长。此外，收购和合作策略有助于市场参与者加强其客户群并扩大其产品组合。以下列出了美国深奥测试市场主要参与者的一些重大进展。

美国心臟协会、美国甲状腺协会、美国食品药物管理局 (FDA)、MyBioSource.com.、内分泌学会、美国国立卫生研究院 (NIH) 是在准备过程中参考的一些主要主要和次要来源关于美国Esoteric 测试市场的报告。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：美国 Esoteric 测试市场格局

  • 概述
  • PEST分析
    • 美国PEST分析

第 5 章：美国深奥测试市场 - 主要产业动态

  • 市场驱动因素
    • 慢性病盛行率上升
    • 早期发现医疗状况的意识不断增强
  • 主要市场限制
    • 缺乏熟练人员且程序成本高
  • 主要市场机会
    • 市场参与者的策略性倡议
  • 未来的趋势
    • 基因检测技术的发展和政府针对罕见疾病的倡议的增加
  • 影响分析

第 6 章：美国 Esoteric 测试市场 - 收入和 2030 年预测

  • 2022 - 2030 年美国 Esoteric 测试市场收入
    • 美国 Esoteric 测试市场（按类型），2020-2030 年
    • 美国 Esoteric 测试市场（按技术），2020-2030 年
    • 美国 Esoteric 测试市场，按最终用户划分，2020-2030 年

第 7 章：美国 Esoteric 测试市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年美国 Esoteric 测试市场收入份额（按技术划分）（%）
  • 化学发光免疫分析
  • 酵素连结免疫吸附测定
  • 质谱
  • 实时萤光定量PCR
  • 流式细胞仪
  • DNA定序
  • 其他的

第 8 章：美国 Esoteric 测试市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 美国 Esoteric 测试市场收入份额，按类型 2022 年和 2030 年 (%)
  • 传染病检测
  • 内分泌检测
  • 肿瘤学测试
  • 毒理学测试
  • 免疫学测试
  • 神经病学测试
  • 其他的

第 9 章：美国深奥测试市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年美国 Esoteric 测试市场收入份额（按最终用户划分）（%）
  • 医院和实验室
  • 独立参考实验室

第10章：美国深奥测试市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 11 章：公司简介

  • Georgia Esoteric & Molecular Laboratory LLC
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • National Medical Services Inc
  • OPKO Health Inc
  • ARUP Laboratories Inc
  • bioMONTR Labs
  • Athena Esoterix LLC
  • Stanford Hospital & Clinics
  • Foundation Medicine Inc

第 12 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00031812

The US Esoteric Testing market is expected to grow from US$ 10.382 billion in 2022 to US$ 31.274 billion by 2030; it is estimated to grow at a CAGR of 14.8% from 2022 to 2030. The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the rising prevalence of chronic diseases and growing awareness of early detection of medical conditions, which are driving the US's esoteric testing market size and growth. Additionally, advancements in genetic testing and rare disease-related initiatives by regulatory authorities are likely to emerge as a significant trend in the market during the forecast period. However, the lack of skilled personnel and the high cost of procedure hinder market growth during the forecast period 2022-2030.

Growing Awareness of Early Detection of Medical Conditions drives the market in the forecast period.

The early diagnosis of diseases helps medical professionals and patients to make various important medical decisions in terms of care, support needs, and financial and legal matters. Obtaining accurate and early diagnosis after noticing cognitive symptoms related to a specific medical condition results in the reversal of symptoms before they are aggravated, followed by an effective and early treatment of patients. It also provides healthcare professionals sufficient time for better decision-making. Laboratory examination procedures are widely performed for the diagnosis of diseases associated with medical specialties, such as neurological disorders, genetic diseases, cancer, and endocrinological disorders. Esoteric testing and genetic testing are performed for the diagnosis of diabetes, cardiovascular disease, lipid disorders, cancer, and genetic diseases.

Various government regulatory bodies are also taking initiatives and conducting campaigns to promote early diagnosis practices. The National Organization for Rare Disorders aims to identify, diagnose, and treat rare disorders through numerous supportive programs, including education, research, advocacy, and patient services. The New York State Rare Disease Workgroup, created in response to legislation passed in New York State (Article 27-L of the Public Health Law), aims to identify best practices that could enhance the awareness of rare diseases. Through such initiatives, people potentially having rare diseases can be referred to specialists, and barriers to their treatments, including financial challenges, can be addressed. Such initiatives to build knowledge regarding available diagnosis options for complex genetic and non-genetic rare disorders favor the growth of the US esoteric testing market.

Report Segmentation and Scope -

The "US Esoteric Testing market" is segmented on the basis of type, technology, and end user. Based on type, the market is segmented into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. In terms of technology, the US esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. In terms of end users, the market is categorized into hospitals and laboratories and independent and reference laboratories.

The US esoteric testing market, by type, is segmented into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. The oncology testing segment held the largest market share in 2022. The infectious disease testing segment is anticipated to register the highest CAGR from 2022 to 2030.

Based on technology, the US esoteric testing market is segmented into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. The chemiluminescence immunoassay segment held the largest market share in 2022. The enzyme-linked immunosorbent assay segment is anticipated to register the highest CAGR of 18.7% during 2022-2030.

Based on end users, the US esoteric testing market is segmented into hospitals and laboratories, as well as independent and reference laboratories. The hospitals and laboratories segment held a larger share of the market in 2022. It is further expected to register a higher CAGR of 15.2% during 2022-2030.

Esoteric tests are generally performed for the analysis of rare and unique substances that are not concluded in regular tests. To perform these tests, clinical laboratories require expertise in relevant specialties. Therefore, large commercial laboratories outsource these complex tests to reference and esoteric testing laboratories. A few of the labs performing esoteric testing in the US include Quest Diagnostics Incorporated, Mayo Medical Laboratories, ARUP Laboratories, Myriad Genetics, Genomic Health, Foundation Medicine, and Laboratory Corporation of America. The number of laboratories that can perform these specialized tests is increasing in the region.

As per an article by the Endocrine Society, published in January 2022, hypogonadism is a common condition in the male population, with a higher prevalence in older men, obese men, and men with type 2 diabetes. 35% of men older than 45 years of age and 30-50% of men with type 2 diabetes or obesity are estimated to have hypogonadism. Moreover, as per the US Census Bureau's estimation, the incidences of hypogonadism in men aged 65 years and more grew from ~35 million in 2000 to ~55 million by 2020. Further, it is estimated to rise to ~87 million by 2050. The surging prevalence of this condition is due to the rise in the geriatric population in the US.

An upsurge in the demand for esoteric testing is also attributed to the rising cases of hepatic cirrhosis. As per Statista, 51,642 adults in the US died from liver disease in 2020. Chronic liver disease/cirrhosis was the 12th leading cause of mortality in the US in 2020; an increase in the incidences of alcoholic cirrhosis is a major risk factor for this disease.

Furthermore, collaborations and partnerships are also expected to propel the market growth of esoteric testing in the US. For instance, as per The National Institutes of Health (NIH) press release of October 2021, NIH, the US Food and Drug Administration, ten pharmaceutical companies, and five non-profit organizations have joined to fasten the development of gene therapies for the 30 million Americans who suffer from rare diseases. Whereas there are nearly 7,000 rare diseases, currently, only 2 heritable diseases have FDA-approved gene therapies. The recently launched Bespoke Gene Therapy Consortium (BGTC), a section of the NIH Accelerating Medicines Partnership (AMP) program and project-lead by the Foundation of NIH, aims to enhance and streamline the development process of gene therapy to support the unmet medical needs of people with rare diseases.

Thus, the burgeoning cases of hypogonadism, hepatic cirrhosis, and other such disease is driving the growth of the esoteric testing market in the US.

Companies in the US's esoteric testing market adopt various organic and inorganic strategies. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the significant developments by key players in the US's esoteric testing market are listed below.

The American Heart Association, The American Thyroid Association, The United States Food and Drug Administration (FDA), MyBioSource.com., The Endocrine Society National Institutes of Health (NIH) are a few of the major primary and secondary sources referred to while preparing the report on the US Esoteric Testing market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US esoteric testing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US esoteric testing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. US Esoteric Testing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 US PEST Analysis

5. US Esoteric Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Chronic Diseases
    • 5.1.2 Growing Awareness of Early Detection of Medical Conditions
  • 5.2 Key Market Restraints
    • 5.2.1 Lack of Skilled Personnel and High Cost of Procedure
  • 5.3 Key Market Opportunities
    • 5.3.1 Strategic Initiatives by Market Players
  • 5.4 Future Trends
    • 5.4.1 Development in Genetic Testing Technologies and Increased Government Initiatives for Rare Diseases
  • 5.5 Impact Analysis

6. US Esoteric Testing Market - Revenue and Forecast to 2030

  • 6.1 US Esoteric Testing Market Revenue (US$ Mn), 2022 - 2030
    • 6.1.1 US Esoteric Testing Market, by Type, 2020-2030 (US$ Million)
    • 6.1.2 US Esoteric Testing Market, by Technology, 2020-2030 (US$ Million)
    • 6.1.3 US Esoteric Testing Market, by End User, 2020-2030 (US$ Million)

7. US Esoteric Testing Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 US Esoteric Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Chemiluminescence Immunoassay
    • 7.3.1 Overview
    • 7.3.2 Chemiluminescence Immunoassay: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Enzyme-Linked Immunosorbent Assay
    • 7.4.1 Overview
    • 7.4.2 Enzyme-Linked Immunosorbent Assay: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Mass Spectrometry
    • 7.5.1 Overview
    • 7.5.2 Mass Spectrometry: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Real-Time PCR
    • 7.6.1 Overview
    • 7.6.2 Real-Time PCR: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Flow Cytometry
    • 7.7.1 Overview
    • 7.7.2 Flow Cytometry: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 DNA Sequencing
    • 7.8.1 Overview
    • 7.8.2 DNA Sequencing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. US Esoteric Testing Market - Revenue and Forecast to 2030 - by Type

  • 8.1 Overview
  • 8.2 US Esoteric Testing Market Revenue Share, by Type 2022 & 2030 (%)
  • 8.3 Infectious Disease Testing
    • 8.3.1 Overview
    • 8.3.2 Infectious Disease Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Endocrinology Testing
    • 8.4.1 Overview
    • 8.4.2 Endocrinology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oncology Testing
    • 8.5.1 Overview
    • 8.5.2 Oncology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Toxicology Testing
    • 8.6.1 Overview
    • 8.6.2 Toxicology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Immunology Testing
    • 8.7.1 Overview
    • 8.7.2 Immunology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Neurology Testing
    • 8.8.1 Overview
    • 8.8.2 Neurology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. US Esoteric Testing Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 US Esoteric Testing Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals & Laboratories
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Laboratories: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Independent & Reference Laboratories
    • 9.4.1 Overview
    • 9.4.2 Independent & Reference Laboratories: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. US Esoteric Testing Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Organic Developments
    • 10.2.1 Overview
  • 10.3 Inorganic Developments
    • 10.3.1 Overview

11. Company Profiles

  • 11.1 Georgia Esoteric & Molecular Laboratory LLC
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Laboratory Corp of America Holdings
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Quest Diagnostics Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 National Medical Services Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 OPKO Health Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 ARUP Laboratories Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 bioMONTR Labs
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Athena Esoterix LLC
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Stanford Hospital & Clinics
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Foundation Medicine Inc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. US Esoteric Testing Market Segmentation
  • Table 2. US Esoteric Testing Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US Esoteric Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Esoteric Testing Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Organic Developments in the US Esoteric Testing Market
  • Table 6. Inorganic Developments in the US Esoteric Testing Market
  • Table 7. Glossary of Terms, US Esoteric Testing Market

List Of Figures

  • Figure 1. US Esoteric Testing Market Segmentation
  • Figure 2. US - PEST Analysis
  • Figure 3. US Esoteric Testing Market: Key Industry Dynamics
  • Figure 4. US Esoteric Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 5. US Esoteric Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. US Esoteric Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 7. Chemiluminescence Immunoassay: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Enzyme-Linked Immunosorbent Assay: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Mass Spectrometry: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Real-Time PCR: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Flow Cytometry: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. DNA Sequencing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. US Esoteric Testing Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 15. Infectious Disease Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Endocrinology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Oncology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Toxicology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Immunology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Neurology Testing: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. US Esoteric Testing Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 23. Hospitals & Laboratories: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Independent & Reference Laboratories: US Esoteric Testing Market - Revenue and Forecast to 2030 (US$ Million)